Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth B Andrews

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Pharmacoepidemiology and Drug Safety|October 30, 2007
Promise and pitfalls of administrative data in evaluating pregnancy outcomesElizabeth B Andrews, Patricia Tennis
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 19, 2003
Additional considerations in longitudinal database researchElizabeth B Andrews, Susan Eaton
Pediatrics|August 1, 2017
The Safety of Medications in Pregnant Women: An Opportunity to Use Database StudiesAndrea V Margulis, Elizabeth B Andrews
Annals of Epidemiology|September 21, 2016
Challenges in studying very rare cancer outcomes and infrequent exposures: example of teriparatide and osteosarcomaElizabeth B Andrews, Alicia Gilsenan, Kirk Midkiff, et al.
Oncology (Williston Park, N.Y.)|August 29, 2009
The REMS publication paradoxElizabeth B Andrews, James A Kaye, Carla Van Bennekom
Expert Review of Clinical Pharmacology|August 10, 2013
Cognitive interviewing in risk minimization survey development: patient and healthcare professional surveysDana B DiBenedetti, Mark A Price, Elizabeth B Andrews
Vaccine|July 31, 2012
A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 seasonPatricia Tennis, Seth L Toback, Elizabeth B Andrews, et al.
Pharmaceutical Medicine|October 24, 2017
Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician SurveyKimberly H Davis, Alex Asiimwe, Laurie J Zografos, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 29, 2020
Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance StudyAlicia Gilsenan, Kirk Midkiff, David Harris, et al.
Clinical Drug Investigation|September 2, 2016
Pharmacoepidemiological Study of Long-Acting β-agonist/Inhaled Corticosteroid Therapy and Asthma Mortality: Clinical ImplicationsCarlos A Camargo, Kourtney J Davis, Elizabeth B Andrews, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Pharmacoepidemiology and Drug Safety|October 30, 2007
Promise and pitfalls of administrative data in evaluating pregnancy outcomesElizabeth B Andrews, Patricia Tennis
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 19, 2003
Additional considerations in longitudinal database researchElizabeth B Andrews, Susan Eaton
Pediatrics|August 1, 2017
The Safety of Medications in Pregnant Women: An Opportunity to Use Database StudiesAndrea V Margulis, Elizabeth B Andrews
Annals of Epidemiology|September 21, 2016
Challenges in studying very rare cancer outcomes and infrequent exposures: example of teriparatide and osteosarcomaElizabeth B Andrews, Alicia Gilsenan, Kirk Midkiff, et al.
Oncology (Williston Park, N.Y.)|August 29, 2009
The REMS publication paradoxElizabeth B Andrews, James A Kaye, Carla Van Bennekom
Expert Review of Clinical Pharmacology|August 10, 2013
Cognitive interviewing in risk minimization survey development: patient and healthcare professional surveysDana B DiBenedetti, Mark A Price, Elizabeth B Andrews
Vaccine|July 31, 2012
A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 seasonPatricia Tennis, Seth L Toback, Elizabeth B Andrews, et al.
Pharmaceutical Medicine|October 24, 2017
Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician SurveyKimberly H Davis, Alex Asiimwe, Laurie J Zografos, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 29, 2020
Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance StudyAlicia Gilsenan, Kirk Midkiff, David Harris, et al.
Clinical Drug Investigation|September 2, 2016
Pharmacoepidemiological Study of Long-Acting β-agonist/Inhaled Corticosteroid Therapy and Asthma Mortality: Clinical ImplicationsCarlos A Camargo, Kourtney J Davis, Elizabeth B Andrews, et al.
Pageof 3